Advanced Biomed Inc. (ADVB)Healthcare | Diagnostics & Research | New York, United States | NasdaqCM
5.10 USD
-0.06
(-1.163%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 5.31 +0.21 (4.118%) ⇧ (July 13, 2026, 5:41 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:18 a.m. EDT
The immediate outlook is bearish due to a confluence of deteriorating technicals and severe operational distress. Price action over the last two weeks shows a distinct downtrend, closing significantly below both the 50-day and 200-day moving averages, which act as heavy resistance. This weakness is compounded by a negative statistical forecast predicting further downside in the coming month, alongside a massive 18% drop from the 200-day average. Fundamentally, the company is in a precarious state with negative free cash flow and negative operating cash flow, indicating it is burning through capital without generating returns. While the trailing P/E appears artificially low due to non-GAAP EPS adjustments, the reality of negative cash generation and a recent reverse stock split suggests deep liquidity or strategic issues. With no dividend to provide income and a balance sheet showing negative asset returns, there is no margin of safety here. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.156340 |
| AutoARIMA | 0.158817 |
| AutoETS | 0.259307 |
| MSTL | 0.275889 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 0.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.162 |
| Excess Kurtosis | -1.36 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 7.737 |
| Market Cap | 8,425,878 |
| Trailing P/E | 1.28 |
| Website | https://www.advanbiomed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6775 |
| Address1 | 122 East 42nd Street |
| Address2 | 18th Floor |
| All Time High | 82.0 |
| All Time Low | 3.61 |
| Ask | 6.78 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 19,330 |
| Average Daily Volume3 Month | 127,486 |
| Average Volume | 127,486 |
| Average Volume10Days | 19,330 |
| Bid | 3.87 |
| Bid Size | 2 |
| Book Value | 6.663 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.1 |
| Current Ratio | 7.383 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 5.51 |
| Day Low | 5.08 |
| Debt To Equity | 7.737 |
| Display Name | Advanced Biomed |
| Earnings Timestamp End | 1,747,339,200 |
| Earnings Timestamp Start | 1,747,339,200 |
| Ebitda | -2,936,914 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.753 |
| Enterprise Value | 5,148,718 |
| Eps Trailing Twelve Months | 4.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.82174 |
| Fifty Day Average Change | 0.27825975 |
| Fifty Day Average Change Percent | 0.057709403 |
| Fifty Two Week Change Percent | -67.75 |
| Fifty Two Week High | 18.2 |
| Fifty Two Week High Change | -13.1 |
| Fifty Two Week High Change Percent | -0.7197802 |
| Fifty Two Week Low | 3.61 |
| Fifty Two Week Low Change | 1.49 |
| Fifty Two Week Low Change Percent | 0.4127424 |
| Fifty Two Week Range | 3.61 - 18.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,741,271,400,000 |
| Float Shares | 629,741 |
| Free Cashflow | -8,488,416 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 31 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.73915 |
| Held Percent Institutions | 0.0 |
| Implied Shares Outstanding | 1,652,133 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Ipo Expected Date | 2,025-03-06 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,771,545,600 |
| Last Split Factor | 1:20 |
| Long Business Summary | Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment, and A+CellScan chips to provide assay products and services to cancer patients. In addition, its immunochromogenic kits include A+CTCE kit to identify epithelial circulating tumor cells and determined by the immunochromogenicity of EpCAM, CK (pan), CD45, and CD14 antibodies; A+CTCM kit to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin, CD45, and CD14 antibodies; A+EMT to identify epithelial-to-mesenchymal circulating tumor cells determined by the immunochromogenicity of cell-surface Vimentin, and CD45 and CD14 antibodies; and A+CM to identify tumor-associated macrophages based on the immunochromogenicity of PD-L1, CD45, and CD14 antibodies. Further, the company is developing A+LCGuard for early screening of lung cancer. Additionally, it establishes and operates medical clinics in the People's Republic of China. The company was founded in 2014 and is headquartered in New York, New York. |
| Long Name | Advanced Biomed Inc. |
| Market | us_market |
| Market Cap | 8,425,878 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1821058753 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 4,757,694 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 8,525,006 |
| Open | 5.0962 |
| Operating Cashflow | -2,907,637 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Post Market Change | 0.21000004 |
| Post Market Change Percent | 4.1176476 |
| Post Market Price | 5.31 |
| Post Market Time | 1,783,978,900 |
| Previous Close | 5.16 |
| Price Hint | 2 |
| Price To Book | 0.765421 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.9 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0599999 |
| Regular Market Change Percent | -1.16279 |
| Regular Market Day High | 5.51 |
| Regular Market Day Low | 5.08 |
| Regular Market Day Range | 5.08 - 5.51 |
| Regular Market Open | 5.0962 |
| Regular Market Previous Close | 5.16 |
| Regular Market Price | 5.1 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 31,690 |
| Return On Assets | -0.21504 |
| Return On Equity | 0.71332 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,652,133 |
| Shares Percent Shares Out | 0.0093 |
| Shares Short | 15,397 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,945 |
| Short Name | Advanced Biomed Inc. |
| Short Percent Of Float | 0.0177 |
| Short Ratio | 0.58 |
| Source Interval | 15 |
| State | NY |
| Symbol | ADVB |
| Total Cash | 2,612,689 |
| Total Cash Per Share | 1.89 |
| Total Debt | 712,529 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 4.0 |
| Trailing P E | 1.275 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.276235 |
| Two Hundred Day Average Change | -1.1762352 |
| Two Hundred Day Average Change Percent | -0.18741095 |
| Type Disp | Equity |
| Volume | 31,690 |
| Website | https://www.advanbiomed.com |
| Zip | 10,168 |